Daiwa Securities Group Inc. Karuna Therapeutics, Inc. Transaction History

Daiwa Securities Group Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$161.01 - $317.85 $2,576 - $5,085	16 Added 11.59%	154 $49,000
Q4 2022 Feb 06, 2023	BUY	$191.53 - $236.82 $3,064 - $3,789	16 Added 13.11%	138 $27,000
Q3 2022 Nov 02, 2022	BUY	$123.79 - $277.42 $1,361 - $3,051	11 Added 9.91%	122 $27,000
Q2 2022 Aug 09, 2022	BUY	$93.97 - $143.33 $2,349 - $3,583	25 Added 29.07%	111 $14,000
Q4 2021 Feb 03, 2022	SELL	$110.64 - $159.4 $1,659 - $2,391	-15 Reduced 14.85%	86 $11,000
Q3 2021 Nov 05, 2021	BUY	$101.2 - $125.87 $4,756 - $5,915	47 Added 87.04%	101 $12,000
Q1 2021 May 03, 2021	BUY	$95.46 - $133.08 $381 - $532	4 Added 8.0%	54 $6,000
Q4 2020 Feb 04, 2021	SELL	$75.23 - $109.23 $7,297 - $10,595	-97 Reduced 65.99%	50 $5,000
Q4 2019 Jan 31, 2020	BUY	$11.44 - $123.99 $1,681 - $18,226	147 New	147 $11,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.